Iron isomaltoside was more effective when compared with iron sucrose in ensuring a rapid improvement in Hemoglobin (Hb) and other iron-related parameters reported a new study published in American Journal of Hematology. A recent study which aimed to compare the efficacy and safety of iron isomaltoside against iron sucrose in gynecology patients with Iron deficiency anemia (IDA) reported that larger doses of iron isomaltoside can be administered within a shorter time to achieve full iron correction and its administration was well tolerated. Source: Derman R, Roman E, Smith‐Nguyen GN, Achebe MM, Thomsen LL, Auerbach M. Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia.
American journal of hematology. 2018 Mar 23. Do you think Iron isomaltoside can be effective in improving the outcomes of IDA patients?
